Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to discuss 2 cheap quality stocks to consider in this heated market.

2 extracted signals · 2 resolved · 0 still active

The Patient Investor profile imageThe Patient Investor11 Oct 2025, 19:05 UTC
Video preview for Friends! In this video, I'm going to discuss 2 cheap quality stocks to consider in this heated market.
Signals
2
Eligible signals in this source
Open
0
Still being tracked
Resolved
2
Evaluable outcomes
Successful
0
Canonical correct result
Failed
2
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis identifies META and AMZN as potential outperformers over the next 20 days. META, currently at $705.30, is noted for its 3.5 billion daily active users and disciplined expense management. A target price is near 1283.29. The analysis emphasizes META's potential for monetization and innovation with a 15% EPS growth over 5 years. AMZN, now down 1% year to date, is recognized for its logistics mode and potential catalyst with the Anthropic partnership in AI. AMZN has the potential target price of 300. Both stocks benefit from poor current sentiment and are growth stories.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  4. Market predictions extracted

    2 eligible signals linked to this case.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.